Nu Skin Enterprises (NYSE:NUS – Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Nu Skin Enterprises to post earnings of $0.21 per share and revenue of $328.70 million for the quarter. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-0.900 EPS and its Q3 2026 guidance at 0.100-0.200 EPS. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Monday, August 10th. The company reported $0.20 EPS for the quarter, hitting the consensus estimate of $0.20. Nu Skin Enterprises had a negative net margin of 15.73% and a positive return on equity of 6.58%. The company had revenue of $320.11 million during the quarter, compared to the consensus estimate of $345.20 million. On average, analysts expect Nu Skin Enterprises to post $0.82 EPS for the current fiscal year and $1.16 EPS for the next fiscal year.
Nu Skin Enterprises Stock Performance
Shares of NUS opened at $4.78 on Tuesday. The firm has a market cap of $232.43 million, a price-to-earnings ratio of -1.07 and a beta of 0.91. The company’s fifty day moving average is $4.77 and its 200-day moving average is $6.40. The company has a quick ratio of 1.24, a current ratio of 1.98 and a debt-to-equity ratio of 0.36. Nu Skin Enterprises has a 12 month low of $4.45 and a 12 month high of $11.67.
Nu Skin Enterprises Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 9th. Investors of record on Friday, August 28th were paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 5.0%. The ex-dividend date of this dividend was Friday, August 28th. Nu Skin Enterprises’s payout ratio is presently -5.37%.
Wall Street Analyst Weigh In
Several equities analysts have commented on the stock. Zacks Research raised shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, October 12th. Weiss Ratings lowered Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
Check Out Our Latest Stock Report on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.
Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.
Further Reading
- Five stocks we like better than Nu Skin Enterprises
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
